In 2017, a patient case in Sangau, West Kalimantan, involving a women with syringomyelia has drawn public attention.
Introduction
In 2017, a patient case in Sangau, West Kalimantan, involving a women with syringomyelia drew public attention. Husband of the patient was arrested, trialed and sentenced for cultivation of Cannabis at his home grounds. Based on data from the case file No.111/Pid. Sus/2017/PN.Sag at Sangau Court of First Instance, it was clear that the cultivation of Cannabis by this man was only for the medical purpose, specifically to treat his wife. 1 The wife had been in severe pain due to syringomelia for many years. Once every two weeks, she needed to be hospitalized. The patient was introduced with Cannabis treatment in 2016. After consuming cannabis, she felt better and could sleep without pain. She confessed that consumption of Cannabis never made her lost of consciousness. Eventually, she died not long after her husband was arrested and trialed.
genus of Cannabis and all part of the plant, including the resin, tetrahydrocannabinol (THC), all its isomer, all its chemical stereoforms, delta-9 THC, and cannabidiol (CBD) are classified as narcotic group I. 3 The aim of this study was to examine whether there was a need to formulate a specific regulation on the use of cannabis for medical purpose.
Methods
This is an explanatory research using qualitative approach. Data source was national and international regulation on narcotics and scientific evidence regarding medical benefit of cannabis. The data was obtained from literature search with following keywords; regulation of Cannabis, medical use of Cannabis, Cannabis medicine. 
Results and Discussion

Legal aspect
Medical aspect
Cannabinoids isolated from Cannabis plant has been extensively studied in medical research. The most frequent used cannabinoids are THC and CBD. Previous clinical trials suggested potential benefits of cannabinoids for alzheimer, dementia, Huntington disease, and other nervous system disorders. 4, 5 Other studies revealed that cannabinoids could reduce tumor growth in animal model of cancer by modulating signalling pathway in cell proliferation. 6 Cannabinoids can also be used for palliative care, particularly in chemotherapy-induced nausea and vomiting due to its anti-emetic effect. 7 In addition, CBD also exhibited anti-convulsant activity that can be used for epilepsy treatment. Compared to THC, CBD has better safety profile.
7-11
Previous study also showed that cannabinoids exhibited modest effect in multiple sclerosis patients, particularly to treat spasticity. Further research are encouraged to compare the effectiveness of Cannabis compared to standard drugs. 13 Australia enacted the law in 2016, while Germany did in 2017. THC and CBD were among the most frrequent used medical Cannabis.
13-22
Our finding showed that there were enough evidence-based data that proved Cannabis can be used for medical purpose. There were also several on-going clinical trials related to the use of cannabis in medical therapy. For that reason, the regulations of medical cannabis should be considered. Document No. LB.02.01/III.03/885/2015 permitted a research using Cannabis in Indonesia. However, this study has never been performed. Many scientific researches can be perfomed with respect to the medical use of Cannabis in Indonesia. Pharmacoeconomic evaluation of the use of medicinal cannabis can also be performed to support the evidence on the clinical and economic benefit on the use of this product. It is worthwile to have a specific regulation on medical Cannabis, that would allow at least the registration of CBD and THC, which are benfeficial to improve for patient care.
Conclusion
It is worth to consider a specific regulation for cannabis to be used for medical purpose, given its beneficial application.
